Dilantin-30 vs. Gabapentin: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Dilantin-30 and Gabapentin. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 453,237 people who take Dilantin-30 and Gabapentin, and is updated regularly.
What is Dilantin-30?
Dilantin-30 has active ingredients of phenytoin. It is often used in epilepsy. eHealthMe is studying from 60 Dilantin-30 users. Check the latest studies of Dilantin-30.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
453,237 people who take Dilantin-30 and Gabapentin are studied.
Drugs being compared in this study:
- Dilantin-30 (phenytoin)
- Gabapentin (gabapentin)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Dilantin-30:
- not at all: 2.45 %
- somewhat: 13.64 %
- moderate: 17.13 %
- high: 40.56 %
- very high: 26.22 %
Gabapentin:
- not at all: 5.84 %
- somewhat: 28.71 %
- moderate: 36.48 %
- high: 20.81 %
- very high: 8.16 %
Want to compare Dilantin-30 with Gabapentin?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Dilantin-30 (33 reports)
- Gabapentin (313,472 reports)
Browse all side effects of Dilantin-30:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gabapentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on phenytoin and gabapentin (the active ingredients of Dilantin-30 and Gabapentin, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Neurontin and Estradiol Cypionate - 2 seconds ago
- Complex Regional Pain Syndrome and Weakness - 3 seconds ago
- Chest Pain Aggravated and drugs of ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate - 6 seconds ago
- Clonazepam and Post Procedural Complication for Men aged 60+ - 9 seconds ago
- Furosemide and Seroquel drug interactions for men aged 60+ - 12 seconds ago
- Claritin and Aleve drug interactions for women aged 30-39 - 14 seconds ago
- Drug interactions of Singulair and Fortamet - 16 seconds ago
- Drug interactions of Tizanidine Hydrochloride and Cevimeline - 18 seconds ago
- Vitamin B6 and Multivitamin drug interactions for women aged 60+ - 18 seconds ago
- Could Exjade cause Acute Leukaemia? - 22 seconds ago